IP Library › Granted Patent US 12,491,109
Granted Patent B2
US 12,491,109 · App. 17/704,645 · Granted Dec 9, 2025

Hyperthermic conditioning capsule

Inventor: Steven J. Daffer (Edina, MN)
Assignee: VISIBELLE DERMA INSTITUTE, INC.
A61F7/0053A61F7/0085A61M19/00A61M21/0094A61N5/0625A63B21/0023A63B21/0552A63B21/0628A63B21/065A63B21/4013A63B21/4021A63B21/4034A63B21/4035A63B22/04A63B22/0605A63B71/04A61F2007/0052A61F2007/0055A61F2007/0057A61F2007/0064A61F2007/0086A61F2007/0093A61F2007/0096A61M11/00A61M2021/0027A61M2021/0044A61M2021/0055A61M2021/0066A61M2021/0072A61M2202/0208A61M2205/051A61M2205/056A61M2205/3368A61M2205/3606A61M2205/3646A61M2205/368A61M2230/06A61M2230/205A61M2230/30A61M2230/50A61N2005/007A61N2005/0637A61N2005/0652A61N2005/0659A63B2208/0252A63B2209/00A63B2213/002A63B2213/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,491,109
App. No.
17/704,645
Granted
Dec 9, 2025
Kind
B2
Abstract

A self-contained, hyperthermic conditioning unit and selectively controllable environment for exercising. The unit comprises a base portion having a bed therein and a removable cover connected to the base portion to enclose a personal compartment within the unit. One or more heating elements provide heat to the personal compartment and one more pieces of physical exercise equipment are provided within the personal compartment.

Claims (48)

1 . A method of conditioning comprising:

providing a capsule comprising:

a base supporting a bed; and

a top hingedly connected to the base;

after a human being at least partially lies on the bed, positioning the top into a closed position to provide a first substantially enclosed space for a body of the human being and a second space for a head of the human being;

monitoring at least one biometric variable of the human being as the human being exercises;

controlling an environmental temperature of the first substantially enclosed space with one or more heating elements to elevate the environmental temperature within the enclosed space to a temperature which elevates a body temperature of the human being while exercising to provide hyperthermic conditioning within the first substantially enclosed space; and

directing cooled air towards the body of the human being after hyperthermic conditioning within the first substantially enclosed space to reduce the body temperature of the human being.

2 . The method of claim 1 and further modifying the environment within the substantially enclosed space by activating one or more of a cooling air fan, a pure oxygen flow, vibration and/or LED lights emitting wavelengths in a visible light spectrum.

3 . The method of claim 1 , wherein the first substantially enclosed space is heated to the elevated environmental temperature with heated air.

4 . The method of claim 1 , wherein the first substantially enclosed space is heated to the elevated environmental temperature with infrared energy.

5 . The method of claim 1 , wherein the first substantially enclosed space is cycled between the elevated environmental temperature to cause the body temperature of the human being to elevate to cause hyperthermic conditioning to a cooler environmental temperature wherein the body temperature of the human being is decreased such that hyperthermic conditioning ceases.

6 . The method of claim 1 , wherein the at least one biometric variable comprises a body temperature of the human being.

7 . The method of claim 1 , wherein the at least one biometric variable comprises heart rate, blood oxygen content and/or blood pressure.

8 . The method of claim 1 , and further comprising emitting light in a visible spectrum within the first substantially enclosed space to provide phototherapy as the human being exercises.

9 . The method of claim 1 , and further comprising utilizing salt blocks within the substantially enclosed space.

10 . The method of claim 1 , and further comprising infusing aroma or concentrated oxygen into the substantially enclosed space as the human being exercises.

11 . A method of controlling an environment while a human being is exercising, the method comprising:

providing a capsule comprising:

a base supporting a bed; and

a top hingedly attached to the base;

after a human being is laying on the bed, positioning the top into a closed position to provide a first substantially enclosed space for at least a body of the human being and a second environment about a head of the human being, the second environment separate from the first substantially enclosed space;

as the human being is exercising while lying on the bed in the enclosed space, monitoring at least one biometric variable of the human being;

heating the first substantially enclosed space to an elevated temperature such that a body temperature of the human being is elevated to provide hyperthermic conditioning within the substantially enclosed space;

directing cooled air toward the body of the human being after hyperthermic conditioning within the first substantially enclosed space to reduce the body temperature of the human being; and

monitoring the at least one biometric variable to provide feedback as the human being exercises.

12 . The method of claim 11 , wherein the first substantially enclosed space is heated to the elevated temperature with heated air.

13 . The method of claim 11 , wherein the first substantially enclosed space is heated with infrared energy.

14 . The method of claim 11 , wherein the first substantially enclosed space is cycled between the elevated temperature to cause the body temperature of the human being to elevate to cause hyperthermic conditioning to a cooler temperature wherein the body temperature of the human being is decreased such that hyperthermic conditioning ceases.

15 . The method of claim 11 , wherein the at least one biometric variable comprises body temperature, heart rate, blood oxygen content and/or blood pressure.

16 . The method of claim 1 , wherein the second space is substantially enclosed.

17 . The method of claim 1 , wherein the environment in the second space is heated with hot air or cooled with chilled air.

18 . The method of claim 1 , wherein the environment in the second space is controlled to introduce enriched oxygen, aromas, light, humidity and/or electrical impulses.

19 . The method of claim 5 , wherein the environment in the second space is heated as the environmental temperature in the first substantially closed space is heated and the environment in the second space is cooled as the environmental temperature in the first substantially closed space is cooled.

20 . The method of claim 5 , wherein the environment in the second space is cooled as the environmental temperature in the first substantially closed space is heated and the environment in the second space is heated as the environmental temperature in the first substantially closed space is cooled.

21 . The method of claim 11 , wherein the second environment is substantially enclosed.

22 . The method of claim 11 , wherein the second environment is heated with hot air or cooled with chilled air.

23 . The method of claim 11 , wherein the second environment is controlled to introduce enriched oxygen, aromas, light, humidity and/or electrical impulses.

24 . A method of controlling an environment while a human being is exercising, the method comprising:

providing a capsule comprising:

a base supporting a bed; and

a top hingedly attached to the base;

after a human being is laying on the bed, positioning the top into a closed position to provide a first substantially enclosed space for at least a body of the human being and a second environment about a head of the human being, the second environment separate from the first substantially enclosed space;

as the human being is exercising while lying on the bed in the enclosed space, monitoring at least one biometric variable of the human being;

heating the first substantially enclosed space to an elevated temperature such that a body temperature of the human being is elevated to provide hyperthermic conditioning within the substantially enclosed space, wherein the first substantially enclosed space is cycled between the elevated environmental temperature to cause the body temperature of the human being to elevate to cause hyperthermic conditioning to a cooler environmental temperature wherein the body temperature of the human being is decreased such that hyperthermic conditioning ceases; and

monitoring the at least one biometric variable to provide feedback as the human being exercises.

25 . The method of claim 24 , and further comprising heating the second environment as the environmental temperature in the first substantially closed space is heated and cooling the second environment as the first environmental temperature in the substantially closed space is cooled.

26 . The method of claim 24 , and further comprising cooling the second environment as the environmental temperature in the first substantially closed space is heated and cooling the second environment as the environmental temperature in the first substantially closed space is cooled.

Continuity (3)
Continuation 16010927 · Jun 18, 2018
Provisional Application 62521802 · Jun 19, 2017
Related Publication 20220218515A1 · Jul 14, 2022
References Cited (94)
US 1221163A · Frink · 1917 [cited by applicant]
US 1643528A · Thurston · 1927 [cited by applicant]
US 1797916A · Kruse · 1931 [cited by applicant]
US 2012221A · Clark et al. · 1935 [cited by applicant]
US 2096128A · Mortrude, Jr. · 1937 [cited by applicant]
US 2240819A · Waly · 1941 [cited by applicant]
US 2300455A · Lukats · 1942 [cited by applicant]
US 2567614A · Merriam · 1951 [cited by applicant]
US D189951S · Cosper · 1961 [cited by applicant]
US 3409915A · Gregoire · 1968 [cited by examiner]
US 3772713A · Roullier · 1973 [cited by applicant]
US 3945058A · Gardner · 1976 [cited by applicant]
US 4031573A · Romanoff · 1977 [cited by applicant]
US 4055863A · Duval · 1977 [cited by applicant]
US D249894S · Brancaccio et al. · 1978 [cited by applicant]
US 4130120A · Kohler, Jr. · 1978 [cited by applicant]
US D255491S · Brancaccio et al. · 1980 [cited by applicant]
US 4258706A · Shank · 1981 [cited by applicant]
US 4277855A · Poss · 1981 [cited by applicant]
US 4389066A · Weir · 1983 [cited by examiner]
US D275605S · Taylor · 1984 [cited by applicant]
US 4565188A · Hardie · 1986 [cited by applicant]
US 4671284A · Wilson et al. · 1987 [cited by applicant]
US 4712538A · Hardie et al. · 1987 [cited by applicant]
US D297863S · Hardie et al. · 1988 [cited by applicant]
US 4833739A · Sakakibara et al. · 1989 [cited by applicant]
US 4862526A · Berger · 1989 [cited by applicant]
US 4884574A · Hardie et al. · 1989 [cited by applicant]
US D317650S · Soder · 1991 [cited by applicant]
US 5101809A · Daffer et al. · 1992 [cited by applicant]
US D326720S · Garrison et al. · 1992 [cited by applicant]
US 5228150A · Parker · 1993 [cited by applicant]
US 5255399A · Park · 1993 [cited by applicant]
US D340992S · Garrison · 1993 [cited by applicant]
US 5416931A · Wolfenden et al. · 1995 [cited by applicant]
US D360469S · Panelli et al. · 1995 [cited by applicant]
US 5441529A · Dorsch · 1995 [cited by applicant]
US 5511254A · O'Brien · 1996 [cited by applicant]
US 5546678A · Dhaemers · 1996 [cited by applicant]
US D377530S · Daffer et al. · 1997 [cited by applicant]
US 5645578A · Daffer et al. · 1997 [cited by applicant]
US D384416S · Daffer et al. · 1997 [cited by applicant]
US 5683437A · Doty · 1997 [cited by applicant]
US 5891186A · Daffer · 1999 [cited by examiner]
US D413388S · Daffer et al. · 1999 [cited by applicant]
US 6004344A · Fujii · 1999 [cited by applicant]
US 6066087A · Tron · 2000 [cited by examiner]
US D453834S · Daffer et al. · 2002 [cited by applicant]
US 6350275B1 · Vreman et al. · 2002 [cited by applicant]
US 6497717B1 · Daffer · 2002 [cited by examiner]
US 6623511B1 · Daffer · 2003 [cited by examiner]
US 7282060B2 · DeBenedictis et al. · 2007 [cited by applicant]
US 7461797B2 · Bhat · 2008 [cited by applicant]
US 7526344B2 · Kim · 2009 [cited by applicant]
US 9808644B2 · Daffer · 2017 [cited by applicant]
US 10744340B2 · Daffer · 2020 [cited by applicant]
US 11311410B2 · Daffer · 2022 [cited by examiner]
US 11504544B2 · Daffer · 2022 [cited by applicant]
US 20020162560A1 · Rogacki · 2002 [cited by examiner]
US 20020198575A1 · Sullivan · 2002 [cited by applicant]
US 20030089370A1 · Daffer · 2003 [cited by examiner]
US 20040260364A1 · Daffer · 2004 [cited by examiner]
US 20060200211A1 · Lin · 2006 [cited by applicant]
US 20060253175A1 · Fan et al. · 2006 [cited by applicant]
US 20070088410A1 · Chung et al. · 2007 [cited by applicant]
US 20070282400A1 · Gorham · 2007 [cited by applicant]
US 20090216299A1 · Dantus · 2009 [cited by applicant]
US 20090216302A1 · Smolka · 2009 [cited by applicant]
US 20090222070A1 · Daffer · 2009 [cited by applicant]
US 20100049282A1 · Wang · 2010 [cited by applicant]
US 20100063487A1 · Straalen · 2010 [cited by applicant]
US 20160051847A1 · Zhang · 2016 [cited by examiner]
US 20160256706A1 · Harrison · 2016 [cited by examiner]
US 20180056111A1 · Chiang · 2018 [cited by examiner]
US 20200330787A1 · Daffer · 2020 [cited by applicant]
DE 725804 · 1944 [cited by applicant]
DE 3915008A1 · 1990 [cited by applicant]
EP 0986985A1 · 2000 [cited by applicant]
FR 2086905A5 · 1971 [cited by applicant]
FR 2629343A1 · 1989 [cited by applicant]
FR 2803512A1 · 2001 [cited by applicant]
GB 1490381 · 1977 [cited by applicant]
JP 8112302A · 1996 [cited by applicant]
JP 11114008A · 1999 [cited by applicant]
WO 0002491A1 · 2000 [cited by applicant]
WO 03034971A2 · 2003 [cited by applicant]
WO 2006108093A2 · 2006 [cited by applicant]
WO 2007036002A1 · 2007 [cited by applicant]
Prosecution History from U.S. Appl. No. 12/396,847, filed Mar. 3, 2009 including: Notice of Allowance and Fee(s) Due mailed Sep. 5, 2017, Non-Final Rejection mailed Nov. 21, 2016, Final Rejection mailed Oct. 6, 2014, No… [cited by applicant]
Prosecution History from U.S. Appl. No. 15/796,141, filed Oct. 27, 2017 including: Notice of Allowance and Fee(s) Due mailed Apr. 9, 2020 and Non-Final Rejection mailed Dec. 23, 2019. [cited by applicant]
Prosecution History for corresponding U.S. Appl. No. 16/010,927, filed Jun. 18, 2018 including: Notice of Allowance and Fee(s) Due mailed Jan. 3, 2022, Final Rejection mailed Aug. 19, 2021, Non-Final Rejection mailed Ja… [cited by applicant]
Chinese First Correction Notice dated Apr. 8, 2019 for corresponding Chinese Application No. 201820946569.0, filed Jun. 19, 2018. [cited by applicant]
Non-Final Rejection from U.S. Appl. No. 16/922,510, filed Jul. 7, 2020. [cited by applicant]
Prosecution History from U.S. Appl. No. 16/922,510 including Notice of Allowance dated Jul. 19, 2022; Final Office Action dated May 2, 2022 and Office Action dated Dec. 17, 2021. [cited by applicant]